Polycythemia Vera is a rare disorder marked by a continuous rise in the number of red blood cells in the blood, with an ...

She says, the PV aspect means that you have to have phlebotomies regularly. And I think the most crippling thing about that is the fatigue. We are hopeful based on the SANRECO Phase 1 data that ...

Silence Therapeutics PLC (SLN) experienced a notable premarket stock price increase of 5.24%, following its earnings call for the fiscal year 2024. The company’s strategic collaborations and ...

The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis' JAKAFI ...